Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients.
Nony E, Bouley J, Le Mignon M, Lemoine P, Jain K, Horiot S, Mascarell L, Pallardy M, Vincentelli R, Leone P, Roussel A, Batard T, Abiteboul K, Robin B, de Beaumont O, Arvidsson M, Rak S, Moingeon P.
Nony E, et al. Among authors: de beaumont o.
Allergy. 2015 Jul;70(7):795-804. doi: 10.1111/all.12622. Epub 2015 Apr 20.
Allergy. 2015.
PMID: 25846209
Clinical Trial.